SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015834
Filing Date
2021-08-05
Accepted
2021-08-05 16:03:22
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20210630.htm   iXBRL 10-Q 1336744
2 EX-10.2 a102ex080521.htm EX-10.2 89334
3 EX-31.1 crdf-063021exhibit311.htm EX-31.1 10818
4 EX-31.2 crdf-063021exhibit312.htm EX-31.2 10792
5 EX-32.1 crdf-063021exhibit321.htm EX-32.1 6221
6 EX-32.2 crdf-063021exhibit322.htm EX-32.2 6191
  Complete submission text file 0001628280-21-015834.txt   6256785

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20210630.xsd EX-101.SCH 38465
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20210630_cal.xml EX-101.CAL 69667
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20210630_def.xml EX-101.DEF 214093
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20210630_lab.xml EX-101.LAB 527297
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20210630_pre.xml EX-101.PRE 335077
12 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20210630_htm.xml XML 1093728
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 211148075
SIC: 2836 Biological Products, (No Diagnostic Substances)